Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro

Virology

Volumn 313, Issue 2, 2003, Pages 343-353

  Moore, Jennifer S ^a   Rahemtulla, Firoz ^b   Kent, Leigh W ^b   Hall, Stacy D ^a   Ikizler, Mine R ^c   Wright, Peter F ^c   Nguyen, Huan H ^a   Jackson, Susan ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epithelial; HIV 1; Mucosa; Oral

Indexed keywords

ADENOID; ARTICLE; CELL FREE SYSTEM; CELL ISOLATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; GINGIVA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; KERATINOCYTE; MONOCYTE; MONONUCLEAR CELL; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0041419660     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00283-6     Document Type: Article

References (51)

1. Asmuth D.M., Hammer S.M., Wanke C.A. Physiological effects of HIV infection on human intestinal epithelial cells an in vitro model for HIV enteropathy . AIDS. 8:1994;205-211.
2. Baba T.W., Koch J., Mittler E.S., Greene M., Wyand N., Penninck D., Ruprecht R.M. Mucosal infection of neonatal rhesus monkeys with cell-free HIV. AIDS Res. Hum. Retroviruses. 10:1994;351-357.
3. Baba T.W., Trichel A.M., An L., Liska V., Martin L.N., Murphey-Corb M., Ruprecht R.M. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science. 272:1996;1486-1489.
4. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 3:1997;42-47.
5. Braun J., Valentin H., Nugeyre M.T., Ohayon H., Gounon P., Barre-Sinoussi F. Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1. Virology. 225:1996;413-418.
6. Cameron P.U., Freudenthal P.S., Barker J.M., Gezelter S., Inaba K., Steinman R.M. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 257:1992;383-387.
7. Cecilia D., Kewalramani V.N., O'leary J., Volsky B., Nyambi P., Burda S., Xu S., Littman D.R., Zolla-Pazner S. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of cereceptor usage. J. Virol. 72:1998;6988-6996.
8. Chou L.L., Epstein J., Cassol S.A., West D.M., He W., Firth J.D. Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J. Oral. Pathol. Med. 29:2000;394-402.
9. Cook D.G., Fantini J., Spitalnik S.L., Gonzalez-Scarano F. Binding of human immunodeficiency virus type 1 (HIV-1) gp120 to galactosylceramide (GalCer) relationship to the V3 loop . Virology. 201:1994;206-214.
10. Delezay O., Koch N., Yahi N., Hammache D., Tourres C., Tamalet C., Fantini J. Co-expression of CXCR4/fusin and galactosylceramide in the human intestinal epithelial cell line HT-29. AIDS. 11:1997;1311-1318.
11. Dezzutti C.S., Guenthner P.C., Cummins J.E. Jr., Cabrera T., Marshall J.H., Dillberger A., Lal R.B. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 183:2001;1204-1213.
12. Dunn D.T., Newell M.L., Ades A.E., Peckham C.S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 340:1992;585-588.
13. Endo Y., Carroll K.N., Ikizler M.R., Wright P.F. Growth of influenza A virus in primary, differentiated epithelial cells derived from adenoids. J. Virol. 70:1996;2055-2058.
14. Frankel S.S., Tenner-Racz K., Racz P., Wenig B.M., Hansen C.H., Heffner D., Nelson A.M., Pope M., Steinman R.M. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am. J. Pathol. 151:1997;89-96.
15. Han Y., Ventura C.L., Black K.P., Cummins J.E. Jr., Hall S.D., Jackson S. Productive human immunodeficiency virus-1 infection of epithelial cell lines of salivary gland origin. Oral. Microbiol. Immunol. 15:2000;82-88.
16. Harouse J.M., Bhat S., Spitalnik S.L., Laughlin M., Stefano K., Silberberg D.H., Gonzalez-Scarano F. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science. 253:1991;320-323.
17. Hayes I.M., Jordan N.J., Towers S., Smith G., Paterson J.R., Earnshaw J.J., Roach A.G., Westwick J., Williams R.J. Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler. Thromb. 18:1998;397-403.
18. Homsy, J., Meyer, M., Tateno, M., Clarkson, S., Levy, J.A., 1989. The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science 1357-1360.
19. Howell A.L., Edkins R.D., Rier S.E., Yeaman G.R., Stern J.E., Fanger M.W., Wira C.R. Human immunodeficiency virus type 1 infection of cells and tissues from the upper and lower human female reproductive tract. J. Virol. 71:1997;3498-3506.
20. Hussain L.A., Lehner T. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology. 85:1995;475-484.
21. Janoff E.N., Smith P.D. Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management. Gastroenterology. 120:2001;607-621.
22. Jong J.D., Simon F., Groen G.V.D., Baan E., Saragosti S., Brun-Vezinet F., Goudsmit J. V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells. AIDS Res. Hum. Retroviruses. 12:1996;1503-1507.
23. Jordan N.J., Kolios G., Abbot S.E., Sinai M.A., Thompson D.A., Petraki K., Westwick J. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest. 104:1999;1061-1069.
24. Kage A., Shoolian E., Rokos K., Ozel M., Nuck R., Reutter W., Kottgen E., Pauli G. Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticles. J. Virol. 72:1998;4231-4236.
25. Keet I.P.M., van Lent N.A., Sandfort T.G.M., Coutinho R.A., van Griensven G.J.P. Orogenital sex and the transmission of HIV among homosexual men. AIDS. 6:1992;223-226.
26. Krieger J.N., Coombs R.W., Collier A.C., Ross S.O., Speck C., Corey L. Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus evidence for different immunologic controls . J. Infect. Dis. 171:1995;1018-1022.
27. Long D., Berson J.F., Cook D.G., Doms R.W. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. J. Virol. 68:1994;5890-5898.
28. Matsushita S., Robert-Guroff M., Rusche J., Koito A., Hattori T., Hoshino H., Javaheriam K., Takatsuki K., Putney S. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62:1988;2114-3107.
29. Moore J.S., Hall S.D., Jackson S. Cell-associated HIV-1 infection of salivary gland epithelial cell lines. Virology. 297:2002;89-97.
30. Murdoch C., Monk P.N., Finn A. Functional expression of chemokine receptor CXCR4 on human epithelial cells. Immunology. 98:1999;36-41.
31. Newell M.-L. Mechanisms and timing of mother-to-child transmission of HIV-1. AIDS. 12:1998;831-837.
32. Nunes I.P., Johannessen A.C., Matre R., Kistofferson T. Epithelial expression of HLA class II antigens and Fc gamma receptors in patients with adult periodontitis. J. Clin. Periodontol. 21:1994;526-532.
33. Pang, A., Yu, D., An, D.S., Baldwin, G.C., Xie, Y., Poon, B., C, Y.-H., Park, N.-H., Chen, I.S.Y., 2000. Human immunodeficiency virus env-independent infection of human CD4- cells. J. Virol. 74, 10994-11000.
34. Phillips D.M., Zacharopoulos V.R., Tan X., Pearce-Pratt R. Mechanisms of sexual transmission of HIV does HIV infect intact epithelia? Trends Microbiol. 2:1994;454-458.
35. Putney S.D., Matthews T.J., Robey W.G., Lynn D.L., Robert-Guroff M., Mueller W.T., Langlois A.J., Ghrayeb J., Petteway S.R., Weinhold K.J., Fischinger P.J., Wong-Staal F., Gallo R.C., Bolognesi D.P. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science. 234:1986;1392-1395.
36. Qureshi M.N., Barr C.E., Seshamma T., Reidy J., Pomerantz R.J., Bagasra O. Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J. Infect. Dis. 171:1995;190-193.
37. Ramarli D., Giri A., Reina S., Poffe O., Cancedda R., Varnier O., Tridente G., De Luca M. HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation. J. Invest. Dermatol. 105:1995;644-647.
38. Rozenbaum W., Gharkhanian S., Cardon B., Duval E., Coulaud J.P. HIV transmission by oral sex. Lancet. i:1988;1395.
39. Rusche J.R., Lynn D.L., Robert-Guroff M., Langlois A.J., Lyerly H.K., Carson H., Krohn K., Ranki A., Gallo R.C., Bolognesi D.P., Putney S.D., Matthews T.J. Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proc. Natl. Acad. Sci. USA. 84:1987;6924-6928.
40. Schacker T., Collier A.C., Hughes J., Shea T., Corey L. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 125:1996;257-264.
41. Takeda A., Tuazon C.U., Ennis F.A. Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science. 242:1988;580-583.
42. Tan X., Phillips D.M. Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus. Arch. Virol. 141:1996;1177-1189.
43. Van De Perre P., Simonon A., Hitimana D.-G., Dabis F., Msellati P., Mukamabano B., Butera J.-B., Goethem C.V., Karita E., Lepage P. Infective and antiinfective properties of breastmilk from HIV-1-infected women. Lancet. 341:1993;914-918.
44. Vernazza P.L., Eron J.J., Cohen M.S., van der horst C.M., Troiani L., Fiscus S.A. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS. 8:1994;1325-1329.
45. Weissman D., Li Y., Ananworanich J., Zhou L.J., Adelsberger J., Tedder R.F., Baseler M., Fauci A.S. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 92:1995;826-830.
46. Wille J.J., Mansson-Rahemtulla B., Rahemtulla F. Characterization of human gingival keratinocytes cultured in a serum-free medium. Arch. Oral. Biol. 35:1990;967-976.
47. Worgall S., Connor R., Kaner R.J., Fenamore E., Sheridan K., Singh R., Crystal R.G. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages. J. Virol. 73:1999;5865-5874. Yahi N., Sabatier J.-M., Baghdiguian S., Gonzalez-Scarano F., Fantini J. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J. Virol. 1995:1995;320-325.
48. Yahi N., Baghdiguian S., Moreau H., Fantini J. Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 66:1992;4848-4854.
49. Yahi N., Sabatier J.-M., Baghdiguian S., Gonzalez-Scarano F., Fantini J. Synthetic multimeric peptides derived from the principal neutralization domain (V3 loop) of human immunodeficiency virus type 1 (HIV-1) gp120 bind to galactosylceramide and block HIV-1 infection in a human CD4-negative mucosal epithelial cell line. J. Virol. 1995:1995;320-325.
50. Zella, D., Barabitskaja, O., Burns, J.M., Romerio, F., Dunn, D.E., Revello, M.G., Gerna, G., Jr, M.S.R., Gallo, R.C., Weichold, F.F., 1998. Interferon-γ increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells. Blood 91, 4444-4450.
51. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., Ho D.D. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science. 261:1993;1179-1181.